Form 8-K - Current report:
SEC Accession No. 0001193125-21-192663
Filing Date
2021-06-17
Accepted
2021-06-17 07:07:00
Documents
14
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d169231d8k.htm   iXBRL 8-K 45352
2 EX-99.1 d169231dex991.htm EX-99.1 1821
3 EX-99.2 d169231dex992.htm EX-99.2 38163
  Complete submission text file 0001193125-21-192663.txt   227214

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sldb-20210616.xsd EX-101.SCH 3070
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20210616_lab.xml EX-101.LAB 18888
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20210616_pre.xml EX-101.PRE 11860
7 EXTRACTED XBRL INSTANCE DOCUMENT d169231d8k_htm.xml XML 3475
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 211023351
SIC: 2836 Biological Products, (No Diagnostic Substances)